Acuitive Technologies wins FDA clearance for tendon interference screw system

Acuitive Technologies announced today that it received FDA 510(k) clearance for its CitreLock interference screw system.

CitreLock with CitreGen material technology, a next-generation thermoset bioresorbable synthetic polymer, is designed to attach tissue during orthopedic surgeries, including the fixation of ligaments or tendon graft tissue repairs of the shoulder, elbow, wrist, hand, knee and foot extremities, according to a news release.

Allendale, N.J.-based Acuitive’s CitreGen biomaterial is designed on a molecular level to guide tissue regeneration by replicating the cellular biochemical and structural support network. It is comprised mainly of citrate, an anti-microbial and anti-inflammatory molecule that aids in bone regeneration.

Get the full story on our sister site, MassDevice.

Original Article: (http://feedproxy.google.com/~r/MedicalDesignAndOutsourcing/~3/Gr_stLpYCDs/)